DEF: Graphjet Technology Seeks Shareholder Approval for Critical Capital Restructuring and Reverse Stock Split to Avoid Nasdaq Delisting
Proxy Statement
Graphjet Technology is convening an Extraordinary General Meeting to seek shareholder approval for a comprehensive share capital reorganization and a reverse stock split, essential measures aimed at regaining compliance with Nasdaq listing requirements following multiple deficiency notices.
Summary
- Graphjet Technology is holding an Extraordinary General Meeting (EGM) on July 30, 2025, to vote on four key proposals.
- The primary objective of these proposals is to regain and maintain the company's listing on the Nasdaq Global Market.
- Proposal No. 1, the Share Capital Reorganization Proposal, seeks to re-designate and re-classify the company's authorized share capital from US$50,000 divided into 479,000,000 Class A, 20,000,000 Class B, and 1,000,000 Preference Shares (all US$0.0001 par value) to 500,000,000 Class A Ordinary Shares (US$0.0001 par value), converting all existing shares into Class A.
- Proposal No. 2, the Share Consolidation Proposal, contingent on Proposal No. 1, requests approval for a reverse stock split of Class A Ordinary Shares at a ratio between 1-for-50 and 1-for-150, with the exact ratio to be determined by the Board by August 13, 2025. Fractional shares will be rounded up.
- Proposal No. 3, the Charter Amendment Proposal, seeks to adopt amended and restated memorandum and articles of association to reflect the share capital reorganization and consolidation.
- Proposal No. 4, the Adjournment Proposal, allows for the EGM to be adjourned if necessary to solicit further proxies or if the Board deems the other proposals no longer desirable.
- As of the Record Date (July 3, 2025), the company had 148,037,022 Class A Ordinary Shares issued and outstanding.
- The Board unanimously recommends a vote FOR all proposals.
- The company has received multiple Nasdaq deficiency notices, including for minimum bid price (below $1 and later below $0.10), market value of listed securities (below $50,000,000), market value of publicly held shares (below $15,000,000), and delays in filing its Quarterly Report on Form 10-K for September 30, 2024, Annual Report on Form 10-Q for December 31, 2024, and Quarterly Report on Form 10-Q for March 31, 2025.
- Nasdaq denied the company's request for continued listing due to reporting delays, leading to a scheduled trading suspension on June 13, 2025, which was stayed pending an appeal hearing on July 17, 2025.
- The company paid a hearing fee of $20,000.00 to Nasdaq and engaged Laurel Hill Advisory Group, LLC for proxy solicitation at a base fee of $8,500.
Sentiment
Score: 3
Explanation: The sentiment is negative due to multiple Nasdaq non-compliance issues, including delisting threats and significant reporting delays. While the company is taking proactive steps (reverse split, capital reorganization), the underlying issues indicate severe operational and financial challenges that could lead to a loss of public market access and hinder future growth and financing capabilities. The proposed actions are reactive measures to avoid a worse outcome, rather than indicators of strong performance.
Positives
- The company is taking proactive steps, including a proposed reverse stock split and capital reorganization, to address multiple Nasdaq listing deficiencies and maintain its listing.
- The Board of Directors unanimously recommends that shareholders vote in favor of all proposals, indicating internal alignment on the proposed strategy.
- The company has appealed Nasdaq's delisting determination, and the trading suspension has been stayed pending the hearing, allowing shares to continue trading for now.
Negatives
- The company is currently non-compliant with multiple Nasdaq listing rules, including minimum bid price (below $1 and later below $0.10), market value of listed securities (below $50,000,000), and market value of publicly held shares (below $15,000,000).
- There are significant delays in filing required financial reports, specifically the Quarterly Report on Form 10-K for September 30, 2024, the Annual Report on Form 10-Q for December 31, 2024, and the Quarterly Report on Form 10-Q for March 31, 2025.
- Nasdaq has already issued a determination letter denying the company's request for continued listing due to reporting delays, leading to a scheduled trading suspension.
- There is no assurance that the proposed reverse stock split will proportionately increase the share price or maintain it above the minimum bid price, and it could potentially harm liquidity.
- Failure to approve the proposals could result in delisting, leading to reduced liquidity, 'penny share' designation, limited market quotation, decreased news/analyst coverage, and difficulty raising future financing.
Risks
- No assurance that the Share Consolidation will increase the share price proportionately or maintain it above the $1.00 minimum bid price for a sustained period.
- The market price of Class A Ordinary Shares may decrease due to factors unrelated to the Share Consolidation, including future financial and operating performance.
- The liquidity of Class A Ordinary Shares may be harmed by the implementation of the Share Consolidation due to the reduced number of shares outstanding.
- Delisting from the Nasdaq Global Market could lead to trading on less efficient markets like the OTC Bulletin Board or pink sheets, resulting in reduced liquidity and limited market quotation.
- Delisting could result in the company's Class A Ordinary Shares being deemed a 'penny share,' subjecting brokers to more stringent rules and potentially reducing trading activity.
- Delisting could lead to limited news and analyst coverage for the company, impacting investor interest.
- A decreased ability to issue additional securities or obtain additional financing in the future if delisted.
- Failure to become current in public reporting obligations could negatively impact the company's ability to raise capital, as well as its reputation, brand, and financial condition.
- The Share Consolidation could have anti-takeover effects by proportionally increasing the number of authorized shares relative to outstanding shares, potentially making it more difficult for a party to obtain control.
Future Outlook
The company intends to regain compliance with Nasdaq listing standards, particularly the Minimum Bid Price Rule, through the proposed share capital reorganization and reverse stock split. The Board will determine the exact ratio of the share consolidation based on market conditions and the anticipated impact on share price and listing status. However, there is no assurance that these actions will guarantee continued listing or that the share price will increase proportionately or remain above the required thresholds. The company also continues to work diligently to become current in its public reporting obligations, which is critical for its ability to raise capital and maintain its reputation.
Management Comments
- "On behalf of the Board and the officers and employees of the Company, I would like to take this opportunity to thank you for your continued support." Chris Lai, Chief Executive Officer
- The Board has determined that approval of the matters to be considered at the Extraordinary General Meeting is in the best interests of the Company and its Shareholders.
- The Board unanimously recommends a vote FOR each matter to be considered.
Industry Context
Companies facing non-compliance with stock exchange listing rules, particularly minimum bid price and reporting requirements, often resort to corporate actions such as reverse stock splits and capital reorganizations. These actions are common strategies to adjust share price and capital structure to meet regulatory thresholds. The challenges faced by Graphjet Technology reflect broader market and regulatory pressures on smaller or underperforming publicly traded companies to maintain their listing status and access to capital markets.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Share Capital Reorganization | Re-designation and re-classification of authorized share capital from US$50,000 divided into 479,000,000 Class A, 20,000,000 Class B, and 1,000,000 Preference Shares to US$50,000 of 500,000,000 Class A Ordinary Shares, with all existing shares converting to Class A. | Contingent on shareholder approval at EGM on July 30, 2025 | Simplifies the capital structure to a single class of ordinary shares, potentially improving clarity for investors and aligning with common public company structures. |
| Share Consolidation (Reverse Stock Split) | Consolidation of every issued and unissued Class A ordinary share at a ratio within a range of 1-for-50 to 1-for-150, with the exact ratio determined by the Board. Fractional shares will be rounded up. | On or prior to August 13, 2025 (contingent on Share Capital Reorganization approval and Board determination) | Aims to increase the per-share trading price to meet Nasdaq's minimum bid price requirement, thereby preventing delisting. However, it may reduce liquidity and does not guarantee a sustained price increase. |
| Charter Amendment | Adoption of amended and restated memorandum and articles of association (A&R M&A) to reflect the Share Capital Reorganization, Share Consolidation, and terms of the New Class A Ordinary Shares. | July 30, 2025 (contingent on shareholder approval) | Formalizes the changes to the company's capital structure and share rights within its governing documents, ensuring legal and regulatory compliance for the proposed actions. |
| Board Structure | Directors shall be divided into three classes (Class I, Class II, and Class III) with staggered terms of office (1, 2, and 3 years respectively after the Business Combination). | Following the consummation of the Business Combination (not specified in this document, but referenced in the A&R M&A) | Staggered board terms can enhance board stability and continuity but may also make it more difficult for shareholders to effect immediate changes to the board composition. |
| Committee Responsibilities | Formal written charters for the Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee will be adopted, complying with SEC and Designated Stock Exchange rules. The Audit Committee will monitor IPO compliance and review related party transactions. | Ongoing, as per A&R M&A adoption | Strengthens corporate governance by formalizing committee roles and responsibilities, enhancing oversight, particularly in financial reporting, executive compensation, and related party dealings, which is crucial for maintaining public listing standards. |
| Director Appointment and Removal | Directors can be removed with or without cause by an Ordinary Resolution of Members or a resolution of directors. New directors can be appointed by the Board (recommended by a majority of Independent Directors) to fill vacancies or as additional directors. | Ongoing, as per A&R M&A adoption | Provides flexibility for board composition while incorporating a recommendation process by independent directors, potentially balancing management's influence with independent oversight. |
| Indemnification and Insurance | The company shall indemnify existing or former directors, secretaries, and officers against liabilities incurred in the conduct of business, except for actual fraud, willful default, or willful neglect. The company may also pay premiums for insurance against risks, excluding dishonesty. | Ongoing, as per A&R M&A adoption | Protects company leadership from personal financial exposure related to their duties, which is standard practice, but explicitly excludes protection for severe misconduct, aligning with good governance principles. |
Stakeholder Impact
- **Shareholders:** Face potential dilution from future share issuances if the authorized share capital is not proportionally reduced after the reverse split. Will experience a reduction in the number of shares held, though their proportionate ownership interest should remain the same immediately after the reverse split. Risk of reduced liquidity and trading activity if delisted. Potential for 'penny share' designation affecting trading rules. Voting rights are critical for the proposed corporate actions.
- **Investors (General):** The company's ability to maintain its Nasdaq listing is crucial for investor confidence and access to a broader, more liquid market. Delisting could significantly impair the investment's value and marketability.
- **Company Management & Employees:** Continued Nasdaq listing provides access to capital for operations and growth, which indirectly impacts job security and potential for future compensation/equity incentives. Delisting could hinder the company's strategic plans and financial stability.
Next Steps
- Shareholders to vote on the Share Capital Reorganization, Share Consolidation, Charter Amendment, and Adjournment Proposals at the Extraordinary General Meeting on July 30, 2025.
- The Board will determine the exact ratio of the Share Consolidation (between 1-for-50 and 1-for-150) if approved by shareholders.
- The company will issue a press release announcing the Effective Date of the Share Consolidation, on or prior to August 13, 2025.
- The company will file a copy of the ordinary resolution approving the Share Consolidation with the Registrar of Companies in the Cayman Islands.
- The Nasdaq Hearings Panel hearing is scheduled for July 17, 2025, where the company will present its plan to regain and maintain compliance with listing rules.
- The company will file a current report on Form 6-K with the SEC within four business days following the Extraordinary General Meeting to publish final voting results.
- The company intends to actively monitor its market value of listed securities (MVLS) and market value of publicly held shares (MVPHS) to regain compliance by September 1, 2025, and October 22, 2025, respectively.
- The company continues to work diligently to complete and file its delinquent Form 10-K and Form 10-Q reports.
Key Dates
| Date | Description |
|---|---|
| 2024-09-30 | Period end for the Quarterly Report on Form 10-K, which was delayed in filing. |
| 2024-12-31 | Period end for the Annual Report on Form 10-Q, which was delayed in filing. |
| 2025-02-21 | Company received Minimum Bid Price Notice from Nasdaq for non-compliance with the $1 minimum bid price rule (below $1 for 32 consecutive days). |
| 2025-02-28 | Company received Reports Notice from Nasdaq for delay in filing Form 10-K (Sep 30, 2024) and Form 10-Q (Dec 31, 2024). |
| 2025-03-05 | Company received MVLS Notice from Nasdaq for market value of listed securities below $50,000,000 for 30 consecutive business days. |
| 2025-03-31 | Period end for the Quarterly Report on Form 10-Q, which was delayed in filing. |
| 2025-04-25 | Company received MVPHS Notice from Nasdaq for market value of publicly held shares below $15,000,000 for 30 consecutive business days. |
| 2025-04-29 | Deadline to submit a plan to Nasdaq to regain compliance with Rule 5250(c)(1) regarding delinquent reports. |
| 2025-06-04 | Company received Determination letter from Nasdaq denying continued listing due to failure to provide a definitive plan for compliance with reporting rules; trading suspension scheduled for June 13, 2025. |
| 2025-06-11 | Company submitted an appeal to Nasdaq requesting a hearing before the Panel, which stayed the suspension for 15 days. |
| 2025-06-12 | Company received a letter confirming the Staff's determination has been stayed, pending a final written decision by the Panel. |
| 2025-06-13 | Original scheduled date for trading suspension by Nasdaq, which was stayed. |
| 2025-06-18 | Company received notice from Nasdaq for non-compliance with the $0.10 minimum bid price rule (below $0.10 for 10 consecutive trading days), serving as an additional delisting basis. |
| 2025-07-03 | Record Date for shareholders entitled to vote at the Extraordinary General Meeting. |
| 2025-07-11 | Date of the Proxy Statement filing with the SEC. |
| 2025-07-14 | Deadline for the company to regain compliance with Nasdaq reporting requirements (180 days from due date of Initial Delinquent Filing). |
| 2025-07-16 | Approximate mailing date of the Proxy Statement to shareholders. |
| 2025-07-17 | Date of the Nasdaq Hearings Panel hearing regarding delisting. |
| 2025-07-29 | Deadline for internet proxy votes (11:59 p.m. Eastern Time). |
| 2025-07-30 | Date of the Extraordinary General Meeting of Shareholders. |
| 2025-08-13 | Latest effective date for the Share Consolidation, if approved and determined by the Board. |
| 2025-08-20 | Deadline to regain compliance with the $1 minimum bid price rule (180 days from Feb 21, 2025 notice). |
| 2025-09-01 | Deadline to regain compliance with the $50,000,000 MVLS rule (180 days from March 5, 2025 notice). |
| 2025-10-22 | Deadline to regain compliance with the $15,000,000 MVPHS rule (180 days from April 25, 2025 notice). |
Keywords
Nasdaq, Delisting, Reverse Stock Split, Share Consolidation, Share Capital Reorganization, SEC Filing, Proxy Statement, Corporate Governance, Financial Reporting, Compliance, Shareholder Meeting, Stock Price, Liquidity, Capital Raise, Risk Management
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.